You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 23, June 16, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (56)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pulmonary Diseases, Other
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Genetic Disorders
 •Alert me on articles by topic

Proportion of Cystic Fibrosis Gene Mutations Not Detected by Routine Testing in Men With Obstructive Azoospermia

Victor Mak, MD, MSc, FRCSC; Julian Zielenski, PhD; Lap-Chee Tsui, OC, PhD; Peter Durie, MD, FRCPC; Armand Zini, MD, FRCSC; Sheelagh Martin, RN, BScN; Teresa Barry Longley, RN; Keith A. Jarvi, MD, FRCSC

JAMA. 1999;281:2217-2224.

Context  Infertile men with obstructive azoospermia may have mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, many of which are rare in classic cystic fibrosis and not evaluated in most routine mutation screening.

Objective  To assess how often CFTR mutations or sequence alterations undetected by routine screening are detected with more extensive screening in obstructive azoospermia.

Design  Routine screening for the 31 most common CFTR mutations associated with the CF phenotype in white populations, testing for the 5-thymidine variant of the polythymidine tract of intron 8 (IVS8-5T) by allele-specific oligonucleotide hybridization, and screening of all exons through multiplex heteroduplex shift analysis followed by direct DNA sequencing.

Setting  Male infertility clinic of a Canadian university-affiliated hospital.

Subjects  Of 198 men with obstructive (n=149) or nonobstructive (n=49; control group) azoospermia, 64 had congenital bilateral absence of the vas deferens (CBAVD), 10 had congenital unilateral absence of the vas deferens (CUAVD), and 75 had epididymal obstruction (56/75 were idiopathic).

Main Outcome Measure  Frequency of mutations found by routine and nonroutine tests in men with obstructive vs nonobstructive azoospermia.

Results  Frequency of mutations and the IVS8-5T variant in the nonobstructive azoospermia group (controls) (2% and 5.1% allele frequency, respectively) did not differ significantly from that in the general population (2% and 5.2%, respectively). In the CBAVD group, 72 mutations were found by DNA sequencing and IVS8-5T testing (47 and 25, respectively; P<.001 and P=.002 vs controls) vs 39 by the routine panel (P<.001 vs controls). In the idiopathic epididymal obstruction group, 24 mutations were found by DNA sequencing and IVS8-5T testing (12 each; P=.01 and P=.14 vs controls) vs 5 by the routine panel (P=.33 vs controls). In the CUAVD group, 2 mutations were found by routine testing (P=.07 vs controls) vs 4 (2 each, respectively; P=.07 and P=.40 vs controls) by DNA sequencing and IVS8-5T testing. The routine panel did not identify 33 (46%) of 72, 2 (50%) of 4, and 19 (79%) of 24 detectable CFTR mutations and IVS8-5T in the CBAVD, CUAVD, and idiopathic epididymal obstruction groups, respectively.

Conclusions  Routine testing for CFTR mutations may miss mild or rare gene alterations. The barrier to conception for men with obstructive infertility has been overcome by assisted reproductive technologies, thus raising the concern of iatrogenically transmitting pathogenic CFTR mutations to the progeny.


Author Affiliations: Division of Urology, Department of Surgery, Mount Sinai Hospital (Drs Mak, Zini, and Jarvi and Mss Martin and Longley), Department of Genetics (Drs Zielenski and Tsui) and Programme in Integrative Biology (Dr Durie and Ms Martin), Research Institute, The Hospital for Sick Children; Departments of Molecular and Medical Genetics (Dr Tsui), Pediatrics (Dr Durie), Division of Urology, Department of Surgery (Drs Mak, Zini, and Jarvi), and Institute of Medical Science (Dr Jarvi), University of Toronto, Toronto, Ontario.


RELATED ARTICLE

June 16, 1999
JAMA. 1999;281(23):2257-2258.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials
Wilschanski et al.
Am. J. Respir. Crit. Care Med. 2006;174:787-794.
ABSTRACT | FULL TEXT  

Diagnosing CF: sweat, blood and years.
Elborn and Bradley
Thorax 2006;61:556-557.
FULL TEXT  

Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens
Wu et al.
Hum Reprod 2005;20:2470-2475.
ABSTRACT | FULL TEXT  

Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens
Grangeia et al.
Hum Reprod 2004;19:2502-2508.
ABSTRACT | FULL TEXT  

Clinical Manifestations of Cystic Fibrosis Among Patients With Diagnosis in Adulthood
Gilljam et al.
Chest 2004;126:1215-1224.
ABSTRACT | FULL TEXT  

Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens
Dayangac et al.
Hum Reprod 2004;19:1094-1100.
ABSTRACT | FULL TEXT  

Safety issues in assisted reproduction technology: Should ICSI patients have genetic testing before treatment? A practical proposition to help patient information
Aittomaki et al.
Hum Reprod 2004;19:472-476.
ABSTRACT | FULL TEXT  

Improved detection of cystic fibrosis mutations in infertility patients with DNA sequence analysis
Danziger et al.
Hum Reprod 2004;19:540-546.
ABSTRACT | FULL TEXT  

Airway Inflammation and Infection in Congenital Bilateral Absence of the Vas Deferens
Gilljam et al.
Am. J. Respir. Crit. Care Med. 2004;169:174-179.
ABSTRACT | FULL TEXT  

Genes and Male Infertility: What Can Go Wrong?
Maduro et al.
J Androl 2003;24:485-493.
FULL TEXT  

Population Screening in the Age of Genomic Medicine
Khoury et al.
NEJM 2003;348:50-58.
FULL TEXT  

Variant Cystic Fibrosis Phenotypes in the Absence of CFTR Mutations
Groman et al.
NEJM 2002;347:401-407.
ABSTRACT | FULL TEXT  

Analysis by mass spectrometry of 100 cystic fibrosis gene mutations in 92 patients with congenital bilateral absence of the vas deferens
Wang et al.
Hum Reprod 2002;17:2066-2072.
ABSTRACT | FULL TEXT  

Mutations of the Cystic Fibrosis Gene and Intermediate Sweat Chloride Levels in Children
LEBECQUE et al.
Am. J. Respir. Crit. Care Med. 2002;165:757-761.
ABSTRACT | FULL TEXT  

Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens
Josserand et al.
Hum Reprod 2001;16:2093-2097.
ABSTRACT | FULL TEXT  

Characterization of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility
Ollero et al.
Hum Reprod 2001;16:1912-1921.
ABSTRACT | FULL TEXT  

Differential production of reactive oxygen species by subsets of human spermatozoa at different stages of maturation
Gil-Guzman et al.
Hum Reprod 2001;16:1922-1930.
ABSTRACT | FULL TEXT  

Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations
McCallum et al.
Hum Reprod 2001;16:282-288.
ABSTRACT | FULL TEXT  

Mutation in the Gene Responsible for Cystic Fibrosis and Predisposition to Chronic Rhinosinusitis in the General Population
Wang et al.
JAMA 2000;284:1814-1819.
ABSTRACT | FULL TEXT  

Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens
Casals et al.
Hum Reprod 2000;15:1476-1483.
ABSTRACT | FULL TEXT  

Clustering of male infertility in the families of couples treated with intracytoplasmic sperm injection
Meschede et al.
Hum Reprod 2000;15:1604-1608.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.